Cuba in Trinidad and Tobago

Statement by Manuel Marrero Cruz, prime minister of the Republic of Cuba to the debate of the United Nations General Assembly on financing for development in the Covid-19 era. September 29, 2020. 

Mr. Secretary General, Mr. Chairman, Distinguished Heads of State and Government, Permanent Representatives, The COVID-19 pandemic has adversely impacted all countries’ health, finances, economy, employment and society; but developing nations have been hit the worst.   Due to increased health expenses to address the pandemic and the loss of income as a result of paralyzed economy and foreign trade, tax, trade and balance of payments deficits of developing countries have increased, as well as their food insecurity.

Statement by the President of the Republic of Cuba, Miguel Díaz-Canel Bermúdez, at the General Debate of the 75th session of the UNGA.

Mr. Secretary General, Mr. President, A global pandemic has changed everyday life drastically. From one day to the next, millions of people get infected and thousands die even when their life expectancy was longer thanks to development. Hospital systems with high-level services have collapsed and the health structures of poor countries are affected by their chronic lack of capacity. Drastic quarantines are turning the most populated cities into deserted areas. Social life is non-existent except in the digital networks.

Statement by H.E. Mr. Bruno Rodríguez Parrilla, Minister of Foreign Affairs of the Republic of Cuba, at the High-Level Segment of the United Nations General Assembly marking the seventy fifth Anniversary of the UU.NN.

Mr. President; Distinguished delegates: On the seventy fifth anniversary of the United Nations, multilateralism and international Law are being threatened by the greatest power in the world. The US irresponsible behavior is the biggest threat to international peace and security.

Cuba moves closer to our own COVID-19 vaccine.

Authorization granted to the Finlay Vaccine Institute to begin clinical trials of new vaccine in collaboration with Ministry of Public Health institutions. The central state enterprise management group BioCubaFarma reports having received permission to begin clinical trials of a Cuban candidate vaccine to prevent COVID-19, capable of producing a strong immune reaction to a SARS-COV-2 infection.

Pages